Edition:
United States

Dr Hoenle AG (HNLG.DE)

HNLG.DE on Xetra

35.25EUR
28 Apr 2017
Change (% chg)

€0.34 (+0.96%)
Prev Close
€34.92
Open
€34.86
Day's High
€35.25
Day's Low
€34.86
Volume
3,457
Avg. Vol
6,132
52-wk High
€35.25
52-wk Low
€21.50

Latest Key Developments (Source: Significant Developments)

Dr Hoenle Q1 sales down 2 pct at 22.18 million euros
Wednesday, 22 Feb 2017 01:25am EST 

Dr Hoenle AG : Q1 earnings before tax stood at 2.159 million euros (py: 2.687 million euros) and consolidated net income amounted to 1.503 million euros (py: 1.878 million euros) . Q1 sales revenues of 22.180 million euros, which corresponds to a 2.0 pct decrease year-on-year . Q1 EBIT of 2.228 million euros was below prior-year's figure of 2.788 million euros . Looking ahead, management board expects a clear improvement in business development in all segments, particularly in third and fourth quarters .Continues to expect sales revenue of between 95 million euros and 105 million euros for Hoenle Group in financial year 2016/2017 and an operating result of between 14 million and 16 million euros.  Full Article

Dr Hoenle 9-Month EBIT down 7.5 pct to 8.785 mln euros
Tuesday, 16 Aug 2016 05:55am EDT 

Dr Hoenle AG : Sales revenues earned by Hoenle Group increased by 2.4 pct to 68.761 million euros ($77.50 million) in first nine months of financial year 2015/2016 . 9-Month operating result (EBIT) declined by 7.5 pct to 8.785 million euros . Hoenle group expects sales revenues of some 90 to 92 million euros and an operating result (EBIT) of app. 12 to 13 million euros in financial year 2015/2016 . In all, management board expects a significant increase in earnings in financial year 2016/2017 .9-month consolidated net income came to 5.713 million euros (py: 6.709 million euros).  Full Article

Dr Hoenle lowers outlook for current FY
Thursday, 28 Jul 2016 10:30am EDT 

Dr Hoenle AG : Cuts outlook for current FY . Now sees 2015/2016 revenue at 90-92 million euros and EBIT at 12-13 million euros .Expects significant improvement in results in 2016/2017.  Full Article

Dr Hoenle H1 sales slightly up at 44.81 million euros
Friday, 20 May 2016 02:40am EDT 

Dr Hoenle AG : H1 sales revenues of 44.811 million euros ($50.26 million) were slightly up from previous year's figure of 44.207 million euros . H1 consolidated result saw a 17.6 pct decline to 3.561 million euros . H1 EBIT fell from 6.013 million euros in previous year to 5.346 million euros in current financial year .Expects group sales revenues and operating result in financial year 2015/2016 to be roughly on par with previous year's figures.  Full Article

Dr Hoenle Aktiengesellschaft issues FY 2015/2016 outlook in line with analysts' estimates
Tuesday, 15 Dec 2015 12:30am EST 

Dr Hoenle Aktiengesellschaft:Set revenue target of between 95 million and 105 million euros for financial year 2015/2016.Is aiming at 2015/2016 operating profit of 13.5 million to 15.5 million euros.FY 2015/2016 revenue 96.50 million euros - Thomson Reuters I/B/E/S.  Full Article

Dr Hoenle Aktiengesellschaft raises FY 2015 outlook
Thursday, 20 Aug 2015 09:05pm EDT 

Dr Hoenle Aktiengesellschaft:Expects sales of about 90 million euros (previously between 85 million and 95 million euros) for Hoenle Group and operating result of circa 13.5 million euros (previously between 12 million and 14 million euros) in FY 2015.FY 2015 revenue 91.00 million euros - Thomson Reuters I/B/E/S.  Full Article

Dr Hoenle Aktiengesellschaft confirms FY 2014/2015 outlook
Friday, 22 May 2015 12:00am EDT 

Dr Hoenle Aktiengesellschaft:Still assumes sales of between 85 million euros and 95 million euros and operating result of between 12 million euros and 14 million euros for FY 2014/2015.  Full Article

Dr Hoenle's Panacol Elosol to establish joint venture with SKC Co. Ltd.
Wednesday, 20 May 2015 11:05am EDT 

Dr Hoenle Aktiengesellschaft:Joint venture of Hoenle Group with SKC Co. Ltd.Panacol Elosol GmbH, subsidiary of Dr. Hoenle, concluded cooperation agreement with SKC Co. Ltd.Panacol Elosol GmbH is to hold a 51 pct stake while SKC Co. Ltd. will hold 49 pct of the shares in the joint company.  Full Article

More From Around the Web